ZA983917B - Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity - Google Patents

Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity

Info

Publication number
ZA983917B
ZA983917B ZA983917A ZA983917A ZA983917B ZA 983917 B ZA983917 B ZA 983917B ZA 983917 A ZA983917 A ZA 983917A ZA 983917 A ZA983917 A ZA 983917A ZA 983917 B ZA983917 B ZA 983917B
Authority
ZA
South Africa
Prior art keywords
antiviral
pharmaceutical
glycyrrhizic acid
composition
antiviral activity
Prior art date
Application number
ZA983917A
Other languages
English (en)
Inventor
Raffaello Pompei
Mario Pinza
Original Assignee
Angelini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Ricerche Spa filed Critical Angelini Ricerche Spa
Publication of ZA983917B publication Critical patent/ZA983917B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA983917A 1997-05-14 1998-05-08 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity ZA983917B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001119A IT1291366B1 (it) 1997-05-14 1997-05-14 Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale

Publications (1)

Publication Number Publication Date
ZA983917B true ZA983917B (en) 1998-11-09

Family

ID=11377123

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA983917A ZA983917B (en) 1997-05-14 1998-05-08 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity

Country Status (27)

Country Link
US (1) US6329339B1 (ja)
EP (1) EP0980254B1 (ja)
JP (2) JP2001525814A (ja)
KR (1) KR100592193B1 (ja)
CN (1) CN1114447C (ja)
AR (1) AR012849A1 (ja)
AT (1) ATE212232T1 (ja)
AU (1) AU740944B2 (ja)
BG (1) BG64748B1 (ja)
CA (1) CA2289550A1 (ja)
CZ (1) CZ291932B6 (ja)
DE (1) DE69803565T2 (ja)
DK (1) DK0980254T3 (ja)
EA (1) EA003126B1 (ja)
ES (1) ES2170501T3 (ja)
GE (1) GEP20022672B (ja)
HK (1) HK1028347A1 (ja)
HU (1) HU224956B1 (ja)
IL (2) IL132651A0 (ja)
IT (1) IT1291366B1 (ja)
PL (1) PL189218B1 (ja)
PT (1) PT980254E (ja)
SK (1) SK283584B6 (ja)
TR (1) TR199902730T2 (ja)
UA (1) UA63955C2 (ja)
WO (1) WO1998051334A1 (ja)
ZA (1) ZA983917B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7151082B2 (en) * 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US7304034B2 (en) * 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
WO2003088914A2 (en) * 2002-04-18 2003-10-30 The University Of Iowa Research Foundation Methods of inhibiting and treating bacterial biofilms by metal chelators
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
EP1668035A2 (en) * 2003-09-11 2006-06-14 Critical Therapeutics, Inc. Monoclonal antibodies against hmgb1
WO2007084253A2 (en) * 2005-11-28 2007-07-26 Medimmune, Inc. High affinity antibodies against hmgb1 and methods of use thereof
WO2007011606A2 (en) * 2005-07-18 2007-01-25 Critical Therapeutics, Inc. USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS
IT1391170B1 (it) * 2008-08-07 2011-11-18 D M G Italia S R L Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale
US9416151B2 (en) 2010-08-25 2016-08-16 Lurong ZHANG Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
EP2608783B1 (en) * 2010-08-25 2018-09-19 Lurong Zhang Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
KR102437992B1 (ko) * 2014-02-21 2022-08-29 고쿠리츠 다이가쿠 호우징 도쿄 가이요우 다이가쿠 노로 바이러스 불활화제 및 그 제조 방법, 노로 바이러스 불활화 방법, 노로 바이러스 불활화용 라이소자임류의 제조 방법, 노로 바이러스 감염의 예방약 또는 치료약, 그리고 노로 바이러스 불활화용 피부 외용제
EP3419629A4 (en) * 2016-02-25 2019-10-30 Applied Biological Laboratories, Inc. COMPOSITIONS AND PROCEDURES FOR PROTECTION AGAINST AIRBORNE PATHOGENES AND IRRITATES
CN109022351B (zh) * 2018-09-28 2021-10-19 广州奇龙生物科技有限公司 重组人溶菌酶的新应用
CN112805027B (zh) * 2020-04-27 2023-10-10 广州新创忆药物临床研究有限公司 一种抗新冠病毒感染的药物与应用
CN112135625B (zh) * 2020-04-27 2021-07-06 广州新创忆药物临床研究有限公司 一种预防或治疗covid-19新冠肺炎的药物及其应用
US20220305092A1 (en) * 2020-04-27 2022-09-29 Guangzhou Century Clinical Research Co., Ltd Medicament and food for preventing or treating novel coronavirus pneumonia covid-19 and use thereof
MX2021005280A (es) 2021-05-04 2022-02-23 Spv Timser S A P I De C V Composicion farmaceutica que contiene triterpenoides pentaciclicos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085800B2 (ja) * 1986-12-19 1996-01-24 エーザイ株式会社 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤
JP2838720B2 (ja) * 1989-10-31 1998-12-16 ゼリア新薬工業株式会社 安定な点眼剤
JP4056099B2 (ja) * 1996-05-09 2008-03-05 森永乳業株式会社 水生動物の寄生生物性疾患の予防および治療剤

Also Published As

Publication number Publication date
EP0980254B1 (en) 2002-01-23
SK154499A3 (en) 2000-08-14
AU7764698A (en) 1998-12-08
IL132651A (en) 2006-10-31
CZ291932B6 (cs) 2003-06-18
SK283584B6 (sk) 2003-10-07
DE69803565T2 (de) 2002-08-08
IL132651A0 (en) 2001-03-19
IT1291366B1 (it) 1999-01-07
DK0980254T3 (da) 2002-05-06
ITMI971119A0 (ja) 1997-05-14
UA63955C2 (uk) 2004-02-16
EA199901024A1 (ru) 2000-06-26
KR100592193B1 (ko) 2006-06-23
HUP0002985A2 (hu) 2001-01-29
PL336802A1 (en) 2000-07-17
ES2170501T3 (es) 2002-08-01
AR012849A1 (es) 2000-11-22
GEP20022672B (en) 2002-04-25
CA2289550A1 (en) 1998-11-19
CZ399199A3 (cs) 2000-04-12
JP2001525814A (ja) 2001-12-11
HK1028347A1 (en) 2001-02-16
ITMI971119A1 (it) 1998-11-14
WO1998051334A1 (en) 1998-11-19
EP0980254A1 (en) 2000-02-23
KR20010012419A (ko) 2001-02-15
PT980254E (pt) 2002-07-31
HUP0002985A3 (en) 2001-04-28
AU740944B2 (en) 2001-11-15
CN1255859A (zh) 2000-06-07
DE69803565D1 (de) 2002-03-14
JP2009102370A (ja) 2009-05-14
US6329339B1 (en) 2001-12-11
EA003126B1 (ru) 2003-02-27
PL189218B1 (pl) 2005-07-29
BG64748B1 (bg) 2006-02-28
CN1114447C (zh) 2003-07-16
HU224956B1 (en) 2006-04-28
TR199902730T2 (xx) 2000-02-21
ATE212232T1 (de) 2002-02-15
BG103968A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
ZA983917B (en) Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
DE69828512D1 (de) Granulierter plasmaproteinfutterzusatz mit erhöhter biowirksamkeit
EP0950665A4 (en) PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM
ZA985352B (en) Barbituric acid derivatives with antimetastatic and antitumor activity.
IL128144A0 (en) Benzamidine derivatives and their use as medicaments with an ltb4-antagonistic activity
HUP0105105A3 (en) Macrolides with anti-inflammatory activity and medicaments containing them
ZA988496B (en) Novel imidazolidine derivatives their preparation their use and pharmaceutical preparations comprising them
AU8016398A (en) Peptides with antiviral activity
ZA9811655B (en) Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same
HUP0003189A3 (en) Pharmaceutical composition comprising fexofenadine and its derivatives
ZA986756B (en) Modified polypeptides with high activity and reduced allergenicity
DE69833460D1 (de) Rekombinantes allergen mit reduzierter enzymatischer aktivität
ZA987633B (en) Dried biologically or therapeutically active preparations
AU8168898A (en) Interferon stimulating protein and uses thereof
IL149506A0 (en) Human heparanase-related polypeptide and nucleic acid
SI0980254T1 (en) Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
AU1821300A (en) Peptides having anti-cancer and anti-inflammatory activity
EP0692537A3 (en) Recombinant gibberellin DNA and its use
NZ325260A (en) Covalent-lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments
HUP9901165A3 (en) Thiamorphinans with neuroprotective activity, pharmaceutical compositions and use of the same
KR0185794B1 (en) Pharmaceutical preparations having anti-fibrotic activity
ZA977043B (en) Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
GB9702189D0 (en) Insecticidal gene and peptide
GB9725149D0 (en) Insecticidal gene and peptide
GB9714099D0 (en) Further anthraquinones with biological activity